logo
Select company
Select metric
$ -43.75MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
14
Sector
36
Industry
50
History
42
$ 3.65Close
$ 2.67 - $ 527 52-Week Range
Ticker Information

Ticker

ONCO

Company Name

ONCONETIX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ONCONETIX INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ONCO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 331.79K$ -44.08M$ -43.75M
3/31/2025$ 529.39K$ -55.82M$ -55.29M
12/31/2024$ 731.35K$ -58.33M$ -57.6M
9/30/2024$ 651.1K$ -50.4M$ -49.74M
6/30/2024$ 448.67K$ -51.97M$ -51.53M
3/31/2024$ 248.94K$ -44.73M$ -44.48M
12/31/2023$ 43.94K$ -36.75M$ -36.71M
9/30/2023$ 6.73K$ -17.79M$ -17.79M
6/30/2023$ 6.96K$ -16.58M$ -16.58M
3/31/2023$ 7.15K$ -14.2M$ -14.19M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ONCONETIX INC's latest trailing twelve months (TTM) EBITDA stands at $ -3.41M.
  • Over the past 5 years, ONCONETIX INC's average EBITDA has been $ -31.99M.
  • The median EBITDA for ONCONETIX INC during this period was $ -36.71M
  • ONCONETIX INC reached its highest EBITDA over the past 5 years at $ -3.41M.
  • The lowest EBITDA recorded by ONCONETIX INC in the same timeframe $ -57.6M

ONCONETIX INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SPRB : SPRUCE BIOSCIENCES INC $ -45.81MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -7.74MVIVS : VIVOSIM LABS INC $ -1.17MXBIO : XENETIC BIOSCIENCES INC $ -3.08MOGEN : ORAGENICS INC $ -9.51MGLTO : GALECTO INC $ -16.57MADTX : ADITXT INC $ -29.78MCDT : CONDUIT PHARMACEUTICALS INC $ -16.52MGTBP : GT BIOPHARMA INC $ -9.39MDRMA : DERMATA THERAPEUTICS INC $ -10.33M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ONCONETIX INC is calculated as follows: EBIT [ $ -3.42M ] + DepAmor [ $ 4.89K ]
(=) EBITDA [ $ -3.41M ]

ONCO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -57.6M

Minimum

Dec 31, 2024

$ -3.41M

Maximum

Dec 31, 2021

$ -31.99M

Average

$ -36.71M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M